Iranian Journal of Pediatrics

Published by: Kowsar

Efficacy of High Dose and Short Course of Deferoxamine Infusion on Cardiac Remodeling 0f Children with Thalassemia Major

Mehdi Shahryari 1 , Nima Mehdizadegan 2 , Hamid Amoozgar 2 , * , Mohammad Borzouee 2 , Gholamhossein Ajami 2 , Sirous Cheriki 2 , Mohammad Reza Edraki 2 , Ali Mohammad Shakiba 2 , Hamid Mohammadi 2 and Kambiz Keshavarz 3
Authors Information
1 Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
2 Neonatal Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
3 Yasuj University of Medical Sciences, Yasuj, Iran
Article information
  • Iranian Journal of Pediatrics: 29 (2); e79684
  • Published Online: February 10, 2019
  • Article Type: Research Article
  • Received: May 25, 2018
  • Revised: November 16, 2018
  • Accepted: November 17, 2018
  • DOI: 10.5812/ijp.79684

To Cite: Shahryari M, Mehdizadegan N, Amoozgar H , Borzouee M, Ajami G, et al. Efficacy of High Dose and Short Course of Deferoxamine Infusion on Cardiac Remodeling 0f Children with Thalassemia Major, Iran J Pediatr. Online ahead of Print ; 29(2):e79684. doi: 10.5812/ijp.79684.

Copyright © 2019, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Zurlo MG, De Stefano P, Borgna-Pignatti C, Di Palma A, Piga A, Melevendi C, et al. Survival and causes of death in thalassaemia major. Lancet. 1989;2(8653):27-30. doi: 10.1016/S0140-6736(89)90264-X. [PubMed: 2567801].
  • 2. Bosi G, Crepaz R, Gamberini MR, Fortini M, Scarcia S, Bonsante E, et al. Left ventricular remodelling, and systolic and diastolic function in young adults with beta thalassaemia major: A Doppler echocardiographic assessment and correlation with haematological data. Heart. 2003;89(7):762-6. doi: 10.1136/heart.89.7.762. [PubMed: 12807852]. [PubMed Central: PMC1767731].
  • 3. Cassinerio E, Roghi A, Pedrotti P, Brevi F, Zanaboni L, Graziadei G, et al. Cardiac iron removal and functional cardiac improvement by different iron chelation regimens in thalassemia major patients. Ann Hematol. 2012;91(9):1443-9. doi: 10.1007/s00277-012-1480-8. [PubMed: 22572843].
  • 4. Bilge AK, Altinkaya E, Ozben B, Pekun F, Adalet K, Yavuz S. Early detection of left ventricular dysfunction with strain imaging in thalassemia patients. Clin Cardiol. 2010;33(7):E29-34. doi: 10.1002/clc.20584. [PubMed: 20641107].
  • 5. Bay A, Baspinar O, Leblebisatan G, Yalcin AS, Irdem A. Detection of left ventricular regional function in asymptomatic children with beta-thalassemia major by longitudinal strain and strain rate imaging. Turk J Haematol. 2013;30(3):283-9. doi: 10.4274/Tjh.2012.0065. [PubMed: 24385808]. [PubMed Central: PMC3878538].
  • 6. Olivieri NF. The beta-thalassemias. N Engl J Med. 1999;341(2):99-109. doi: 10.1056/NEJM199907083410207. [PubMed: 10395635].
  • 7. Hu Z, Metaxas D, Axel L. In vivo strain and stress estimation of the heart left and right ventricles from MRI images. Med Image Anal. 2003;7(4):435-44. doi: 10.1016/S1361-8415(03)00032-X. [PubMed: 14561549].
  • 8. Magri D, Sciomer S, Fedele F, Gualdi G, Casciani E, Pugliese P, et al. Early impairment of myocardial function in young patients with beta-thalassemia major. Eur J Haematol. 2008;80(6):515-22. doi: 10.1111/j.1600-0609.2008.01054.x. [PubMed: 18284626].
  • 9. Yip G, Abraham T, Belohlavek M, Khandheria BK. Clinical applications of strain rate imaging. J Am Soc Echocardiogr. 2003;16(12):1334-42. doi: 10.1067/j.echo.2003.09.004. [PubMed: 14652617].
  • 10. Marcus RE, Davies SC, Bantock HM, Underwood SR, Walton S, Huehns ER. Desferrioxamine to improve cardiac function in iron-overloaded patients with thalassemia major. Lancet. 1984;1(8373):392-3. doi: 10.1016/S0140-6736(84)90439-2. [PubMed: 6141447].
  • 11. Aldouri MA, Wonke B, Hoffbrand AV, Flynn DM, Ward SE, Agnew JE, et al. High incidence of cardiomyopathy in beta-thalassaemia patients receiving regular transfusion and iron chelation: Reversal by intensified chelation. Acta Haematol. 1990;84(3):113-7. doi: 10.1159/000205046. [PubMed: 2123060].
  • 12. Davis BA, Porter JB. Long-term outcome of continuous 24-hour deferoxamine infusion via indwelling intravenous catheters in high-risk beta-thalassemia. Blood. 2000;95(4):1229-36. [PubMed: 10666195].
  • 13. Rashidi F, Kousarian M, Rahmani A, Farzin D, Bahoush G. [Effect of high dose intravenous desferal on complicated beta thalassemia patients]. Mazandaran Med J. 2005;47(6-13). Persian.
  • 14. D'Andrea A, Stisi S, Bellissimo S, Vigorito F, Scotto di Uccio F, Tozzi N, et al. Early impairment of myocardial function in systemic sclerosis: Non-invasive assessment by Doppler myocardial and strain rate imaging. Eur J Echocardiogr. 2005;6(6):407-18. doi: 10.1016/j.euje.2005.01.002. [PubMed: 16293527].
  • 15. Hamdy AM. Use of strain and tissue velocity imaging for early detection of regional myocardial dysfunction in patients with beta thalassemia. Eur J Echocardiogr. 2007;8(2):102-9. doi: 10.1016/j.euje.2006.02.004. [PubMed: 16564231].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments